Skip to main content
. 2022 Oct 29;14(21):5344. doi: 10.3390/cancers14215344

Figure 3.

Figure 3

Pan-cancer differential expression of SLC2A1 in different pathologic stages in indicated tumor types from TCGA database (AK) (ns, p ≥ 0.05; *, p < 0.05; **, p < 0.01; ***, p < 0.001).